In the present study, we investigated the role of bone marrow cells during development of experimental Graves’ disease and TED and whether the bone marrow is involved in the immune inhibitory effect of the IGF-1R/IR antagonist linsitinib. This evidence concerns the gene INSR and Graves disease.